We are a contract research organization located in Montreal, Canada providing bioanalytical testing services for almost 30 years (since 1994). Our laboratory provides bioanalytical testing for non-regulated and regulated studies using liquid-chromatography and mass spectrometry (LC-MS/MS), as well as supporting preclinical and clinical programs by providing pharmacokinetic and toxicokinetic (PK/TK) reporting.

Our experienced and passionate team constitutes of more than 35 scientists including experienced method development scientists, technical & support scientists, and study directors all working in 3670 sq ft of purpose-designed laboratories. Compounds analyzed in the laboratory constitute of novel pharmaceutical compounds and generic drugs such as small molecules, peptides, and protein based. Our team has extensive expertise in a variety of different matrices, including plasma, serum, skin, liver, lung, spleen, heart, brain, kidney, aorta, bone marrow, and various eye tissues.

We have an extensive list of over 250 clinical plasma assays available to complete drug interaction (DDI) studies along with others being added on an ongoing basis. Good Laboratory Practice (GLP) accreditation by the Standards Council of Canada (SCC) has been maintained since 2015 (biannual audits), and we are GMP compliant based on Health Canada inspections in 2020 and 2022. Our data and reports also meet US FDA requirements (last FDA on-site audit 2018 and virtual audit in 2022).

Our customizable Services:

• Bioanalysis in plasma, serum ad tissues
• Pharmacokinetics & Toxicokinetic statistical analysis and reporting
• Method transfer and development
• Regulated & Non-regulated mass spectrometry-based quantification

State-Of-The-Art instrumentation:

• 12 LC-MS/MS (AB Sciex API 6500 QTRAP; API 6500+; API 5000),
• Ultra-performance liquid chromatography (UPLC) (Shimadzu)
• Automation (Hamilton Microlab Star).